Southwestern Internal Medicine Conference: Bone disease in kidney failure: Diagnosis and management

R. E. Cronin

Research output: Contribution to journalArticle

2 Scopus citations


Recent technologic and therapeutic advances have improved the life of the patient with end-stage renal disease. High efficiency and high-flux hemodialyzer membranes have shortened the time required to dialyze, and recombinant erythropoietin has all but eliminated anemia as a major cause of morbidity, but the problem of renal osteodystrophy remains. The following discussion examines the spectrum of bone and joint disease in the patient with end-stage renal disease. The diagnostic and therapeutic strategies currently being tried in the management of these disorders are discussed.

Original languageEnglish (US)
Pages (from-to)192-205
Number of pages14
JournalAmerican Journal of the Medical Sciences
Issue number3
StatePublished - Jan 1 1993



  • Aluminum-induced osteomalacia
  • Calcitriol
  • Deferoximine
  • Hemodialysis-related amyloidosis
  • Parathyroidectomy
  • Renal osteodystrophy

ASJC Scopus subject areas

  • Medicine(all)

Cite this